📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. (2022)

First Author: Alexander JL

Attributed to: Unravelling the role of CD8+ T-cells in immune checkpoint inhibitor induced colitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2022-005490

PubMed Identifier: 36113896

Publication URI: http://europepmc.org/abstract/MED/36113896

Type: Journal Article/Review

Volume: 10

Parent Publication: Journal for immunotherapy of cancer

Issue: 9

ISSN: 2051-1426